American Well Co. (NYSE:AMWL – Get Rating) CFO Robert Shepardson sold 24,986 shares of the business’s stock in a transaction dated Wednesday, June 1st. The stock was sold at an average price of $3.57, for a total value of $89,200.02. Following the completion of the sale, the chief financial officer now owns 963,289 shares in the company, valued at $3,438,941.73. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.
NYSE:AMWL opened at $3.86 on Friday. American Well Co. has a fifty-two week low of $2.52 and a fifty-two week high of $14.76. The firm’s 50 day moving average is $3.52 and its two-hundred day moving average is $4.53.
American Well (NYSE:AMWL – Get Rating) last released its quarterly earnings results on Monday, May 9th. The company reported ($0.26) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.22) by ($0.04). The firm had revenue of $64.20 million for the quarter, compared to analyst estimates of $64.94 million. American Well had a negative net margin of 79.91% and a negative return on equity of 16.72%. American Well’s revenue for the quarter was up 11.5% on a year-over-year basis. During the same period in the previous year, the business posted ($0.16) earnings per share. On average, equities analysts predict that American Well Co. will post -0.98 earnings per share for the current fiscal year.
AMWL has been the topic of several research analyst reports. Guggenheim started coverage on American Well in a research note on Wednesday, April 13th. They issued a “buy” rating and a $6.00 price objective on the stock. Piper Sandler reissued an “overweight” rating and issued a $5.00 target price (down from $7.00) on shares of American Well in a research report on Monday, May 16th. Zacks Investment Research downgraded American Well from a “hold” rating to a “sell” rating in a research report on Tuesday, May 10th. The Goldman Sachs Group initiated coverage on American Well in a research report on Friday, February 11th. They set a “neutral” rating and a $6.00 price target on the stock. Finally, Wells Fargo & Company dropped their target price on American Well from $6.00 to $4.00 and set an “equal weight” rating on the stock in a research report on Monday, February 28th. One investment analyst has rated the stock with a sell rating, four have given a hold rating and five have issued a buy rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $8.93.
About American Well (Get Rating)
American Well Corporation operates as a telehealth software company that enables digital delivery of care for healthcare. The company products offer urgent care; scheduled visits; acute behavioral health; telestroke; pediatrics; retail health, school health, and home settings. Its application offers urgent care; pediatrics; therapy; menopause nutrition; end-stage renal disease and dialysis; dermatology care; behavioral health therapy; and musculoskeletal care.
- Get a free copy of the StockNews.com research report on American Well (AMWL)
- Okta On Verge Of Multi-Week Rally
- Xiaomi Co: Facing Macro Headwinds
- Alibaba Group: Rallying on Fundamentals & Improved Macro Backdrop
- Investing in Chewy Will Require More Than One Earnings Report
- Hormel Foods Sends A Message To The Market
Want More Great Investing Ideas?
- Bear Market Game Plan!
- The 10 Best Stocks to Own in 2022
- 7 Stocks to Buy and Hold Forever
- 3 Stocks to DOUBLE This Year
Receive News & Ratings for American Well Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Well and related companies with MarketBeat.com's FREE daily email newsletter.